<DOC>
	<DOCNO>NCT01092611</DOCNO>
	<brief_summary>The purpose long-term follow-up study ass long-term health status HIV-infected subject previously participate GSK-sponsored trial evaluate investigational HIV vaccine 732462 . This study provide additional data concern long-term benefits/risks associate vaccination . No vaccine administer study period . Vaccines administer primary study .</brief_summary>
	<brief_title>Long-term Follow-up Participants From Studies Evaluating GSK HIV Vaccine</brief_title>
	<detailed_description>General information health subject persistence cellular humoral immune response study vaccination evaluate .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>All subject must satisfy ALL follow criterion study entry : HIVinfected subject . Previous participation study evaluate GSK HIV vaccine 732462 . Written inform consent obtain subject . The following criterion check time study entry . If ANY exclusion criterion applies , subject must include study : â€¢ Subjects receive complete vaccination course previous study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>HIV-infected subject</keyword>
	<keyword>long-term follow-up study</keyword>
	<keyword>HIV therapeutic vaccine</keyword>
</DOC>